Press Release FeedGet the RSS feed
Menu

Browse press releases

The newest releases come first, each with its full text here and a link to its original. Try the filters to narrow them down.

10,635 resultsPage 264 of 500, newest first
  1. FinanceStoutStout Acquires Flightline to Advance Its AI StrategyAcquisition builds on more than 12+ months of co-development and brings agentic AI technology and expertise into Stout — Stout announced the acquisition of Flightline, an agentic AI company that collaborated with Stout for more than 12+ months to...
  2. FinanceIceCure MedicalIceCure Highlights Clinical Data and Strong Physician Engagement for ProSense® Breast Cancer Cryoablation at EUSOBI 2026Scientific presentations, research posters and clinical workshops featured ProSense® breast cancer cryoablation and highlighted strong physician engagement across Europe — IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure," "IceCure Medical" or...
  3. FinanceSCIENTURE Reports Approximately $1.22 Million in Unaudited Preliminary Q3 2026 Revenue, Achieving 256% Sequential GrowthContinued Arbli™ sales growth, combined with REZENOPY™ commercial launch in August 2026 and initial wholesale shipments, drives significant sequential revenue growth
  4. FinanceSysco CorporationSysco To Announce First Quarter Fiscal Year 2027 Financial Results on November 3Companies: SyscoSysco Corporation (NYSE:SYY) will host a conference call and webcast to discuss its first quarter fiscal year 2027 financial results at 10 a.m. EDT on Tuesday, November 3, 2026.
  5. FinanceSunrise Realty Trust Announces ISS and Glass Lewis Support for Merger-Related ProposalsSunrise Realty Trust, Inc. (“SUNS” or the “Company”) (Nasdaq: SUNS), a lender on the Tannenbaum Capital Group (“TCG”) Real Estate platform, today announced that independent proxy advisory firms Institutional Shareholder Services Inc. (“ISS”) and Glass, Lewis & Co., LLC (“Glass Lewis”) each recommended that SUNS stockholders vote “FOR” both proposals at the Company’s October 23, 2026 special meeting of stockholders (the “Special Meeting”), consistent with the Company’s Board of Directors’ unanimous recommendation: (1) approval of the issuance of approximately 8,464,955 shares of SUNS common stock in connection with the Company’s proposed merger with Southern Realty Trust Inc. (“SRT”) (the “Merger”) (the “Stock Issuance Proposal”) and (2) adjournment of the Special Meeting, if necessary or appropriate, to solicit additional proxies in support of the Stock Issuance Proposal. ISS issued its recommendation on October 1, 2026, and Glass Lewis on October 6, 2026.
  6. FinanceSunrise Realty Trust Announces $20 Million Stock Repurchase ProgramSunrise Realty Trust, Inc. (“SUNS” or the “Company”) (Nasdaq: SUNS), a lender on the Tannenbaum Capital Group (“TCG”) Real Estate platform, today announced that on October 12, 2026, its Board of Directors (the “Board”) authorized a common stock repurchase program to repurchase up to $20.0 million of SUNS common stock through December 31, 2027 (the “Repurchase Program”). The Repurchase Program will become effective only upon closing of SUNS’ proposed merger with Southern Realty Trust Inc. (“SRT”) (the “Merger”), and no shares will be repurchased under the Repurchase Program before that time.
  7. FinanceOracleOracle Commits $1 Million to Doña Ana County Flood RecoveryCompanies: Oracle CorporationDoña Ana County, New Mexico and Austin, Texas—Oct 13, 2026 Oracle is making a $1 million commitment to support residents and communities affected by recent flooding in Doña Ana County. The funding will be administered by the Community Foundation of Southern New Mexico (CFSNM) through its Greatest Needs Impact Fund for Doña Ana County. Recent heavy rainfall has caused significant flooding across portions of Doña Ana C
  8. FinanceLelantos Holdings Inc.Lelantos Holdings Announces Cancellation of 60 Million ESOP SharesLelantos Holdings, Inc. (OTCID: LNTO) ("Lelantos" or the "Company") today announced the cancellation of 60,000,000 shares of common stock previously held under the Company's Employee Stock Ownership Plan ("ESOP").The cancelled shares will be removed from the Company's issued and outstanding share count.Following Through on Shareholder CommitmentsThe cancellation advances the Company's previously communicated commitment to cancel 100...
  9. FinanceImmutep LimitedImmutep Regains Compliance with Nasdaq Minimum Bid Price RequirementImmutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep" or "the Company"), a late-stage immunotherapy company targeting cancer and autoimmune diseases, today announced that it has received written notification from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq"), dated 12 October 2026 (US Eastern Time), confirming that the Company has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5450(a)(1).
  10. FinanceEnlight Renewable Energy Ltd.Enlight to Report Third Quarter 2026 Financial Results on Tuesday, November 3, 2026Enlight Renewable Energy (TASE: ENLT; NASDAQ:ENLT), a global renewable energy developer and independent power producer, will release its financial results for the third quarter of 2026 before market open on Tuesday, November 3, 2026.
  11. FinanceMBX Biosciences, Inc.MBX Biosciences to Participate in Upcoming November Investor ConferencesMBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel precision peptide therapies for the treatment of endocrine and metabolic disorders, today announced that Steve Hoerter, Chairman and Chief Executive Officer, and Sam Azoulay, M.D., Chief Medical Officer, will present at, and participate in, the following upcoming investor conferences:
  12. FinanceMetagenomi Therapeutics, Inc.Metagenomi Therapeutics, Inc. to Participate in the Chardan 10th Annual Healthcare ConferenceMetagenomi Therapeutics, Inc. (Nasdaq: MGX) (the “Company”), an in vivo genome editing company capitalizing on its proprietary technologies to create curative genetic medicines for patients, today announced that Jian Irish, Ph.D., M.B.A., President and Chief Executive Officer of the Company, will participate in a panel discussion titled “Genome Editing: Next-Wave Platforms Beyond CRISPR 1.0” at the Chardan 10th Annual Healthcare Conference on Tuesday, October 20, 2026, at 10:30 a.m. ET, being held in New York, NY.